{"id":"NCT01906866","sponsor":"Neurim Pharmaceuticals Ltd.","briefTitle":"Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities","officialTitle":"A Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Circadin® to Alleviate Sleep Disturbances in Children With Neurodevelopmental Disabilities","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2018-03-27","completion":"2018-03-27","firstPosted":"2013-07-24","resultsPosted":"2018-10-30","lastUpdate":"2024-04-23"},"enrollment":125,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Sleep Disorders"],"interventions":[{"type":"DRUG","name":"Circadin 2/5/10 mg","otherNames":["Active arm"]},{"type":"DRUG","name":"Placebo","otherNames":["Control"]}],"arms":[{"label":"Circadin 2/5/10 mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to establish the efficacy and safety of Circadin in children with neurodevelopmental disorders and to determine the dose, this randomized, placebo-controlled study is planned to evaluate the efficacy of a double-blind, 13 week treatment period with Circadin 2/5mg in improving maintenance of sleep, sleep latency and additional parameters in children with neurodevelopmental disabilities. The efficacy and safety of Circadin 2/5 mg will continue to be assessed during an open-label extension period of 13 weeks.","primaryOutcome":{"measure":"Total Sleep Time (TST)","timeFrame":"13 weeks","effectByArm":[{"arm":"Circadin 2/5/10 mg","deltaMin":51.03,"sd":null},{"arm":"Placebo","deltaMin":18.71,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"=0.035"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":null},"locations":{"siteCount":28,"countries":["United States","Finland","France","Netherlands","United Kingdom"]},"refs":{"pmids":["31982581","29096777"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":60},"commonTop":["Non-serious adverse events","Non-serious adverse events","Non-serious adverse events","Non-serious adverse events","Non-serious adverse events"]}}